[ Price : $8.95]
Eisai Inc. files a supplemental NDA for Fycompa (perampanel) seeking monotherapy use for treating partial-onset seizures with or w...[ Price : $8.95]
In approving an Amgen biosimilar for the first copy of Abbotts Humira (adalimumab) for multiple inflammatory diseases (see story),...[ Price : $8.95]
Rep. Mike Fitzpatrick (R-PA) asks the House Energy and Commerce Committee for a hearing to investigate FDAs failings over medical ...[ Price : $8.95]
Federal Register Notice: FDA has extended the comment period until 11/26 for a guidance on Procedures for Evaluating Appearance Is...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance on Self-Identification of Generic Drug Facilities, Sites, and Organization...[ Price : $8.95]
Wells Pharmacy Network recalls all sterile human and veterinary products prepared since February due to an FDA concern over a lack...[ Price : $8.95]
Federal Register Notice: FDA announces a 12/6 meeting of its Bone, Reproductive and Urologic Drugs Advisory Committee that will di...[ Price : $8.95]
Federal Register Notice: FDA detemines the regulatory review period for Eisais NDA for Fycompa (perampanel) that applies to a pate...